INS and type 2 diabetes mellitus: This clearly supraphysiological glucose concentration was chosen as it was reported for mouse islets that 25 mmol/L glucose with or without palmitate inhibited the 1st phase of insulin release after short-term incubation (3 d) [29] similar to the situation described for type 2 diabetes mellitus.